The fund owned 395,208 shares of the biotechnology company’s stock after buying an additional 75,214 shares during the period. Teachers
Archives
The Rhumbline Advisers Raises its position in Biogen Inc. (BIIB) as a favorable investment target.
The fund owned 357,364 shares of the biotechnology company’s stock after buying an additional 8,533 shares during the period. Rhumbline
Impact Score Of Puma Biotechnology Inc (NYSE:PBYI) At 81
Puma Biotechnology Inc (NYSE:PBYI) shares have been stated a daily sentiment score of 0.56 for web articles published on 2016-12-09.
Technical Buzz on Generex Biotechnology Corporation (OTCPK:GNBT)
In looking at the Value Composite score for Generex Biotechnology Corporation (OTCPK:GNBT), we see that the firm has a rank
Average Directional Index Review for Bioshares Biotechnology Product (BBP)
Currently, the 14-day ADX for Bioshares Biotechnology Product (BBP) is 21.29. Generally speaking, an ADX value from 0-25 would indicate
The 170 Shares of Biogen Inc. (BIIB) are sold by the Duff & Phelps Investment Management Co.
The fund owned 2,910 shares of the biotechnology company’s stock after selling 170 shares during the period. Duff & Phelps
The Galena Biopharma Inc. (GALE) Receives Buy Rating from Maxim Group
The brokerage currently has a $1.00 price objective on the biotechnology company’s stock. Several other brokerages also recently commented on …
ImmunoGen Inc. (IMGN) Receives $6.43 Average PT from Brokerages
Fisher Asset Management LLC now owns 253,701 shares of the biotechnology company’s stock valued at $751,000 after buying an additional
Cowen and Company Reaffirms Buy Rating for Heron Therapeutics Inc. (HRTX)
Cowen and Company currently has a $40.00 price objective on the biotechnology company’s stock. A number of other equities analysts
Innovative Young Biotechnologist Award
The Department of Biotechnology has invited applications for Innovative Young Biotechnologist Award (IYBA) to identify and nurture outstanding …